跳至主要内容
临床试验/NCT05797220
NCT05797220已完成不适用

Effect of Additional Topical Diltiazem on Botulinum Toxin Injection for Chronic Anal Fissure: Retrospective Analysis of 217 Patients

Istanbul Medipol University Hospital1 个研究点 分布在 1 个国家目标入组 217 人开始时间: 2016年11月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
217
试验地点
1
主要终点
Fissure healing at 1 month

研究概览

简要总结

Anal fissure (AF) is a painful tear extending from the anal canal to the dentate line. Although the exact pathophysiology is not known, an increase in anal tonus, decreased ano-dermal blood flow and local ischemia are possible mechanisms. The most effective treatment modality in chronic AF is lateral internal sphincterotomy however, incontinence rates are still reported as high as 8-30%. Topical diltiazem and botulinum toxin (BT) injection are good alternatives to surgery with lack of persistent side effects, easy applicability, and reproducibility, however, recurrence rates were reported up to 50% for each. A combination of BT with topical diltiazem may provide better results in terms of healing and recurrence. In this retrospective analysis a comparison of BT injection alone and BT injection combined with topical diltiazem treatment was performed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with complaints longer than 8 weeks (chronic anal fissure)
  • Patients who completed 24 months of follow-up (3rd day, 10th day, and 2nd-month face-to-face clinic visits and 6, 12, and 24 months phone calls)
  • Patients who received conservative treatments including topical diltiazem and nitrites

排除标准

  • Patients with previous anal surgery (lateral internal sphincterotomy, hemorrhoidectomy, anal fistula)
  • Patients with inflammatory bowel diseases
  • Patients with accompanying anorectal disease (hemorrhoids, anal fistula, abscess)
  • Patients who underwent botulinum toxin injection within 1 year before recruitment
  • Patients with anterior, lateral, or multiple fissures
  • Comorbidities (AIDS, sexually transmitted disease, tuberculosis, leukemia)
  • Pregnancy
  • Prescription of calcium canal blockers or nitrites
  • Hypersensitivity to diltiazem or botulinum toxin
  • Patients without anal pain

研究组 & 干预措施

Botulinum toxin group

The procedures were performed at outpatient clinic without anesthesia. Lyophilized 100 IU BT Type-A (BOTOX, Alergan, CA, USA) was applied after diluted with 1 cc saline. A 26-G injector was used to inject 25 unit toxin in every 4 quadrants, to the alignment of clock 12, 3, 6, and 9 to internal anal sphincters.

干预措施: Botulinum Toxin Type A Injection [Botox] (Drug)

Botulinum toxin plus topical diltiazem group

The procedures were performed at outpatient clinic without anesthesia. Lyophilized 100 IU BT Type-A (BOTOX, Alergan, CA, USA) was applied after diluted with 1 cc saline. A 26-G injector was used to inject 25 unit toxin in every 4 quadrants, to the alignment of clock 12, 3, 6, and 9 to internal anal sphincters. After BT injection, topical 2% diltiazem gel was prescribed, applied 2 times per day for 10 days (2 doses of 1 gr each per day). No selection criteria were used when recommending this treatment; it was randomly suggested to some for a while during the cohort since the surgeon believed it might enhance the efficacy of BT.

干预措施: Botulinum Toxin Type A Injection [Botox] + Diltiazem Hydrochloride 20 Mg/G Rectal Gel (Drug)

结局指标

主要结局

Fissure healing at 1 month

时间窗: 1 month

Evaluation of complete epithelization of the fissure by the principal investigator by rectal examination

Days to pain-free defecation

时间窗: 1 month

Patient reported time until pain-free defecation. This will be evaluated on 3rd day, 10th day and 1-month outpatient visits.

次要结局

  • Complete healing at 48 months(48 months)

研究者

发起方
Istanbul Medipol University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effect of Additional Topical Diltiazem on Botulinum... | 临床试验